Division of Pediatric Allergy and Immunology, Ankara City Hospital, Ankara, Turkey.
Division of Pediatric Allergy and Immunology, Ankara City Hospital, Ankara, Turkey.
Ann Allergy Asthma Immunol. 2020 Aug;125(2):202-207. doi: 10.1016/j.anai.2020.04.003. Epub 2020 Apr 12.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used in children and can frequently cause hypersensitivity reactions. Rates of confirmed NSAID hypersensitivity (NSAID-H) in children are low.
To evaluate the results of drug provocation tests (DPTs) with NSAIDs and to evaluate the difficulties encountered in the classification of NSAID-H in children.
The study included patients with suspected NSAID-H who were examined in our clinic between January 1, 2015, and December 31, 2018. Oral provocation tests with NSAIDs were performed and reactions were classified according to the European Academy of Allergy and Clinical Immunology position paper on NSAID-H.
A total of 243 patients (57.2% male patients) presented with suspected NSAID-H during the study period. Of these, 168 patients (69.1%) had a history of reaction to ibuprofen. Isolated skin involvement was the most frequent symptom (86%). A total of 238 DPTs were performed with the suspected agents and 34 had positive results. The families of 12 patients refused provocation testing with the suspected agent or aspirin and these patients could not be diagnosed. Of the 231 patients, 47 patients (20.3%) received a diagnosis of NSAID-H. Twenty patients with NSAID-H could not be classified because their guardians did not consent to further testing with aspirin.
Performing diagnostic tests is important in patients with no contraindications. Characterizing these reactions in children can be difficult because of the coexistence of indistinguishable symptoms in their history and DPTs, as well as the need for multiple provocation tests. Therefore, further research is needed on this subject.
非甾体抗炎药(NSAIDs)在儿童中广泛使用,常可引起超敏反应。儿童确诊的 NSAID 超敏反应(NSAID-H)发生率较低。
评估 NSAID 药物激发试验(DPT)的结果,并评估儿童 NSAID-H 分类中遇到的困难。
本研究纳入了 2015 年 1 月 1 日至 2018 年 12 月 31 日期间在我院就诊的疑似 NSAID-H 患者。进行 NSAID 口服激发试验,并根据欧洲变态反应与临床免疫学学会关于 NSAID-H 的立场文件对反应进行分类。
研究期间共有 243 例(57.2%为男性患者)疑似 NSAID-H。其中 168 例(69.1%)有布洛芬过敏史。最常见的症状是孤立性皮肤受累(86%)。共对 238 例疑似药物进行了 DPT,其中 34 例结果阳性。由于 12 例患者的家属拒绝进行可疑药物或阿司匹林激发试验,因此有 12 例患者无法诊断。在 231 例患者中,47 例(20.3%)被诊断为 NSAID-H。由于监护人不同意进一步进行阿司匹林检测,20 例 NSAID-H 患者无法分类。
在无禁忌证的患者中进行诊断性检测很重要。由于儿童的病史和 DPT 中存在无法区分的症状,以及需要进行多次激发试验,因此儿童的这些反应难以明确分类。因此,需要对此问题进行进一步研究。